We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 1-10 of 961

Unusual Removal Situation Yields Favorable Result
  • Reed Smith LLP
  • USA
  • January 19 2017

We’re pretty familiar with most diversity-based removal techniques, so when we see something unusual, we sit up and take notice (as we did with


Obama FDA’s Parting Shot On Off-Label Promotion And The First Amendment
  • Reed Smith LLP
  • USA
  • January 18 2017

We haven’t digested it yet, so this isn’t a substantive post, but we wanted to make our readers aware that today the FDA made an announcement, which


Medicare Secondary Payer - A Lot Less Boring Now
  • Reed Smith LLP
  • USA
  • January 16 2017

We’ve previously written several posts (not recently) on Medicare secondary payer (“MSP”) issues - which we characterized as “boring.” The recent MSP


Guest Post - MDL Court: Preemption Leaves No “Glimmer of Hope” for Labeling Claims Against a Pharmacy
  • Reed Smith LLP
  • USA
  • January 12 2017

What follows is a post authored by Jaclyn Setili, a Reed Smith associate. She is discussing what we believe is the first extension of


Medical Causation Experts Pass Daubert Test, But Cannot Opine on Plaintiff’s Lack of Capacity to Sign Release
  • Reed Smith LLP
  • USA
  • January 11 2017

We typically write about product liability cases, not medical malpractice actions. But the two are not mutually exclusive, and similar issues arise


“Regulatory Causation” Roundup
  • Reed Smith LLP
  • USA
  • January 10 2017

Last week’s Westlaw search (that’s one way we find the cases we discuss in the Blog) brought a blast from the past - a case almost three years old


Lipitor MDL Court Grants Pfizer’s Omnibus Summary Judgment Motion: No Evidence of Causation
  • Reed Smith LLP
  • USA
  • January 9 2017

For those of us who spend large chunks of our professional lives in mass tort MDLs, expressions like “settlement Inventory” are ubiquitous. It is too


SDNY Applies Preemption in Favor of Branded Drug
  • Reed Smith LLP
  • USA
  • January 4 2017

Yesterday we commenced the dreary process of taking down the Christmas decorations. The German nutcrackers slid back into their cartons. Stockings


Guest Post - Failure to Warn Claim Dead on Arrival Without Testimony from Prescribing Physician
  • Reed Smith LLP
  • USA
  • January 3 2017

This is a guest post from Michael Salimbene, an associate at Reed Smith. It’s about learned intermediary causation, and the need for prescriber


Decision Limiting Duties regarding Automated External Defibrillators Does Not Shock The Conscience
  • Reed Smith LLP
  • USA
  • December 30 2016

Ponder the following: A man attends an exercise class at a facility run by a local religious institution. Assume that he belonged to this facility